According to David Nazarian, MD, a board-certified internist at My Concierge MD in Beverly Hills, California, patients start at the lowest dose and gradually increase it based on their needs and how their bodies respond to the medication
Key market dynamics are shaped by the trend toward multi-agonist compounds, which offer superior efficacy by targeting multiple hormonal pathways, and the development of oral formulations that enhance patient convenience and adherence
Tirzepatide is similar to semaglutide, but it is actually a dual agonist and works by two mechanisms instead of one
Some providers add a separate monthly membership of $74 to $149 on top of medication, and some raise the medication price as your dose climbs toward maintenance
Moreover, most studies to date have been conducted on a small-scale, study site basis, without a formal means of supporting a larger, landscape perspective